Category: Market News

Amaroq Ltd. (LSE:AMRQ) has started its 2026 resource drilling programme at the Nanoq gold project in South Greenland, targeting greater drill density and continuity following high-grade results from its 2025 exploration campaign.

Three company-owned drill rigs have been deployed at Nanoq, with the programme focused primarily on the Central Zone. The planned campaign is expected to be broadly comparable with the 4,807 metres of drilling completed during 2025.

Amaroq will also conduct step-out drilling at the parallel West 1 Zone, providing an opportunity to test the wider extent of mineralisation beyond the principal area of exploration.

The programme is designed to generate the geological information required to support a potential maiden Mineral Resource Estimate later in 2026. Achieving that milestone would represent an important step in Amaroq’s strategy to establish Nanoq as its next high-grade gold project alongside the producing Nalunaq mine.

In parallel with drilling, Amaroq is conducting preliminary metallurgical testing at SGS Lakefield in Canada. The work will assess whether material from Nanoq could be processed using the existing gravity and flotation flowsheet at Nalunaq.

If metallurgical compatibility is demonstrated, the existing processing infrastructure could potentially support bulk sampling and trial processing of Nanoq material, providing another route for evaluating the project as exploration advances.

Amaroq is also assessing infrastructure requirements around Nanoq, including a potential harbour and access road. These improvements are being considered as part of plans to strengthen site access from 2027 onwards.

Better infrastructure could reduce logistical costs and make it easier to conduct larger exploration and development programmes as the project progresses.

The combination of resource drilling, metallurgical testing and early infrastructure planning represents a broader push to move Nanoq beyond exploration towards a more defined development opportunity. Results from the 2026 drilling campaign will be particularly important in determining whether the company can establish sufficient continuity and scale to support a maiden resource estimate.

More about Amaroq Ltd.

Amaroq Ltd. is a Greenland-focused mining and exploration company developing gold and strategic metal assets across South and West Greenland.

Its principal asset is the producing Nalunaq gold mine in South Greenland, while its wider exploration portfolio includes prospective projects targeting gold, copper, nickel, rare earth elements and other base and precious metals.

The company is pursuing a strategy of developing a full-cycle mining business in Greenland, combining production from established assets with exploration and development of additional mineral projects.

Amaroq shares trade on the London Stock Exchange under the symbol AMRQ.

Genuit (LSE:GEN) maintained its profit guidance after reporting higher first-half revenue, with price increases and contributions from recent acquisitions helping offset weaker underlying volumes and continued pressure across its end markets.

First-half revenue increased 3.4% to £307.8 million, although underlying operating profit declined 1.6% as softer like-for-like volumes and cost inflation linked to the Middle East conflict weighed on margins.

Statutory operating profit fell 30.1%, reflecting exceptional costs associated with the group’s ongoing transformation programme. Leverage increased to 1.6 times following acquisitions completed in 2025, although cash generation improved during the period.

Genuit maintained its interim dividend at 4.2p per share, reflecting management’s confidence in the group’s medium-term prospects despite the more challenging near-term trading environment.

The company has responded to cost pressures with double-digit price increases alongside accelerated cost-control and business simplification measures. These actions are expected to provide greater margin support as they take effect.

Genuit has also completed the integration of Monodraught and Davidson, with both acquisitions delivering margins and synergies ahead of the company’s previous expectations. Their performance provides an additional contribution as weaker organic market conditions continue to affect the wider business.

Management sees several regulatory and infrastructure programmes supporting longer-term demand, including the Future Homes Standard, Warm Homes Plan, social housing policies and the AMP8 water investment cycle.

These initiatives could create opportunities across Genuit’s water management, heating, ventilation and sustainable building solutions as regulatory requirements and investment increasingly focus on energy efficiency, infrastructure resilience and decarbonisation.

The company expects the combination of pricing measures and operational efficiencies to support margins, while sustainability-related demand could become a more significant growth driver from 2027.

Genuit’s broader financial position remains relatively solid, although weaker cash conversion and increased leverage compared with previous years remain areas to monitor.

Technical indicators are generally supportive, with positive momentum and the shares trading above shorter-term moving averages. However, the price remains below its 200-day moving average, while the Stochastic indicator is approaching overbought territory.

Valuation and income characteristics provide additional support, with a moderate P/E ratio and a dividend yield of approximately 4.76%.

More about Genuit Group

Genuit Group is the UK’s largest provider of sustainable water and climate products and solutions for the built environment.

Its portfolio includes systems for drainage, stormwater management, heating, ventilation and controls, serving markets influenced by environmental regulation, infrastructure investment and the transition towards lower-carbon buildings.

The group increasingly incorporates low-carbon materials and recycled content into its products as part of its strategy to help customers improve building efficiency and reduce environmental impact in the UK and international markets.

Genuit Group shares trade on the London Stock Exchange under the symbol GEN.

Thor Explorations (LSE:THX) delivered record first-half revenue, EBITDA and net profit for the six months ended June 30, 2026, supported by strong operating margins and a growing net cash position as the company continued exploration across its West African portfolio.

Second-quarter revenue reached $77.6 million, while net profit came in at $48.7 million. Thor ended the period with an adjusted net cash position of $218.6 million, providing financial flexibility as it invests in exploration and potential mine-life extensions.

Gold production and sales during the second quarter were lower than a year earlier, although the company retains a substantial stockpile of lower-grade material equivalent to approximately two years of plant feed. This inventory provides additional processing flexibility and helps reduce near-term dependence on newly mined ore.

At the Segilola gold mine in Nigeria, processing operations maintained high recovery rates and experienced minimal downtime. Thor is continuing its life-of-mine extension drilling programme, including work designed to assess mineralisation at depth and the potential for underground development beneath the existing open-pit design.

Regional exploration around Segilola is also progressing, with geochemical programmes identifying additional gold anomalies that could provide targets for future drilling.

Elsewhere in West Africa, Thor continued extensive exploration programmes in Senegal and Côte d’Ivoire using reverse circulation, RAB/air-core drilling and soil sampling.

Work in Senegal has extended known mineralised systems along a corridor spanning approximately 10 kilometres, highlighting the potential to expand the company’s resource base beyond its producing Segilola operation. Exploration in Côte d’Ivoire is similarly aimed at advancing prospective gold targets and building a broader development pipeline.

Thor also reported improvements in several environmental measures during the quarter. Raw water withdrawals and greenhouse gas emissions declined significantly compared with Q2 2025, while emissions intensity per ounce of gold produced remained stable.

Community investment continued around Segilola through school and infrastructure improvements, support for local businesses and other social programmes. These initiatives form part of the company’s efforts to maintain relationships with communities surrounding its operations.

The combination of record first-half financial performance, a substantial net cash position and continued exploration gives Thor flexibility to pursue both mine-life extension opportunities at Segilola and potential resource growth elsewhere in West Africa.

Future exploration results will be important in determining whether the company can convert its regional targets and deeper Segilola mineralisation into additional resources capable of supporting longer-term production.

More about Thor Explorations

Thor Explorations Ltd is a gold producer and exploration company focused on West Africa, with its flagship Segilola gold mine located in Nigeria.

Alongside gold production at Segilola, the company operates exploration programmes across Nigeria, Senegal and Côte d’Ivoire aimed at extending existing mineralised systems, identifying new resources and evaluating potential underground mining opportunities.

Segilola currently operates as an open-pit mine, supported by a significant stockpile of ore that provides additional flexibility for plant operations.

Thor Explorations shares trade on the London Stock Exchange under the symbol THX.

East Star Resources (LSE:EST) has reported further progress at its Verkhuba copper deposit joint venture in Kazakhstan, with drilling advancing and partner Xinhai completing its initial A$1.5 million investment commitment.

Seven diamond drill holes totalling more than 1,350 metres have now been completed as part of a programme focused on resource conversion and feasibility work. A second drill rig has also been mobilised to increase the pace of the campaign.

The drilling is designed to improve understanding of the mineralisation expected to support the early years of any potential mining operation. Importantly for East Star, the programme is being fully funded by Xinhai under the joint venture arrangement.

Xinhai has now satisfied its Stage 1 investment obligation of A$1.5 million, giving it an initial 15% interest in the Verkhuba joint venture company. Completion of this investment also triggers the transfer of the Verkhuba licence into the JV vehicle.

For East Star, the structure provides a capital-efficient route for advancing Verkhuba. The company remains fully carried through to production under the terms of the joint venture and is positioned to retain a 30% interest in any producing mine.

This arrangement could allow East Star to maintain meaningful exposure to the project’s potential development without directly funding the substantial expenditure normally required to move an exploration asset through feasibility and towards production.

The immediate focus remains on completing the drilling programme and generating the technical information required for resource conversion and feasibility assessment. Results from the campaign should provide greater clarity around the areas that could form the basis of initial mining activity.

Despite progress at Verkhuba, East Star’s broader financial position remains a consideration. The company currently generates no revenue and continues to report losses, while higher cash consumption during 2025, renewed debt and declining equity add financial pressure.

Technical indicators are comparatively more supportive, with the shares trading above major moving averages and momentum indicators remaining positive. Valuation is more difficult to assess while earnings remain negative and no dividend yield is available.

More about East Star Resources

East Star Resources is an exploration and development company focused on copper and gold opportunities in Kazakhstan.

Its portfolio includes the Verkhuba polymetallic deposit and a second volcanogenic massive sulphide exploration target in the same region. The company also participates in a large-scale gold exploration joint venture with Endeavour Mining.

East Star additionally holds copper porphyry and epithermal gold prospects within an established mineral belt, giving the company exposure to several exploration and development opportunities across Kazakhstan.

East Star Resources shares trade on the London Stock Exchange under the symbol EST.

Oriole Resources (LSE:ORR) has reported encouraging early-stage exploration results from its 90%-owned Eastern Central Licence Package in Cameroon, including rock-chip gold grades of up to 28.40 grams per tonne at the Niambaram licence.

Follow-up rock-chip sampling over previously identified soil anomalies at Niambaram has outlined three mineralised areas. Gold mineralisation was identified within quartz veins and brecciated felsic dykes hosted by orthogneiss.

The geological setting has similarities to the nearby Mbe licence, where a JORC Inferred Mineral Resource of 1.66 million ounces of gold has been reported. Oriole holds a 50% interest in Mbe, which is contiguous with its Eastern Central Licence Package.

At the Ndom licence, Oriole has completed infill soil and auger sampling across the ND01 target. The programme is intended to provide a clearer understanding of potential mineralisation beneath extensive alluvial cover after limited rock-chip sampling returned only low-grade gold results.

Samples from Ndom and Niambaram are planned for analysis using Portable PPB’s detectORE technology, which enables faster field-based gold assays. Results will help determine priorities for further exploration across the Eastern licence package during the 2026/27 field season.

At the same time, Oriole is narrowing its exploration footprint in Cameroon. The Western Central Licence Package has been revoked following persistent difficulties accessing the properties and competing interests associated with hunting concessions.

The financial impact of losing those licences may be limited because Oriole had committed only minimal expenditure to the Western package. Their removal could also allow the company to concentrate exploration spending on the Eastern licences, where recent results and proximity to the Mbe resource provide clearer targets for follow-up work.

The Niambaram results are still early-stage and do not establish a mineral resource. Further sampling and exploration will therefore be needed to determine the continuity, scale and economic significance of the identified gold mineralisation.

Oriole’s wider outlook remains constrained by its financial position. The company generates no revenue and continues to report losses and negative operating and free cash flow, leaving exploration activity dependent on access to external capital.

Technical indicators are also subdued, with a negative MACD and RSI below 50. Traditional valuation measures provide limited support while earnings remain negative and no dividend yield is available. A relatively low-leverage balance sheet and meaningful equity provide some offset to these risks.

More about Oriole Resources PLC

Oriole Resources PLC is an AIM-listed gold exploration and development company focused on Central and West Africa.

Its principal interests in Cameroon include the 90%-owned Eastern Central Licence Package and a 50% interest in the contiguous Mbe licence, where a JORC Inferred Mineral Resource of 1.66 million ounces of gold has been reported.

The company’s exploration strategy focuses on identifying and advancing new gold targets around its existing resource base, with the aim of increasing project scale and strengthening the portfolio’s potential appeal to future partners and investors.

Oriole Resources shares trade on the London Stock Exchange under the symbol ORR.

BSF Enterprise PLC (LSE:BSFA) has signed heads of terms for a worldwide commercialisation and supply agreement covering its proprietary ETSYL bioactive peptide, opening a potential new route to revenue across luxury skincare and the wider cosmetics market.

The agreement with SCHAKAU Managementberatung GmbH gives SCHAKAU exclusive global rights to ETSYL for cosmetic applications for an initial 10-year period, subject to meeting agreed sales volume targets.

SCHAKAU plans to use ETSYL as the principal active ingredient in its ultra-luxury HANDS OF GOD skincare brand while also pursuing opportunities to license the peptide to other businesses in the cosmetics sector.

Under the proposed arrangement, SCHAKAU will fund approximately €300,000 of expenditure covering clinical validation, regulatory activities and brand development. This allows BSF to advance commercialisation without directly funding those elements of the programme.

Importantly, BSF will retain full ownership of the intellectual property associated with ETSYL. Its wholly owned subsidiary, 3D Bio-tissues, is also expected to generate near-term revenue from supplying the raw material required for commercial products.

The agreement provides an additional potential income stream through third-party licensing. Revenue generated from licensing ETSYL to other cosmetics businesses will be divided equally between BSF and SCHAKAU.

The structure gives BSF a relatively capital-light route for commercialising its peptide technology while retaining ownership of the underlying intellectual property. Successful development of the HANDS OF GOD brand or additional B2B licensing agreements could provide further evidence that the group’s scientific platform can generate commercial opportunities beyond its core biotechnology activities.

However, the 10-year exclusivity remains dependent on sales volumes, making commercial adoption an important measure of the agreement’s longer-term value.

BSF’s wider outlook also remains constrained by persistent losses and negative cash flow. Technical indicators are similarly weak, with the shares trading below key moving averages and momentum remaining negative.

Valuation provides limited support while the company remains loss-making, and the absence of a dividend means investors remain primarily dependent on future commercial progress and execution.

More about BSF Enterprise PLC

BSF Enterprise PLC is a biotechnology company developing tissue engineering, lab-grown materials and bioactive technologies through its wholly owned subsidiary 3D Bio-tissues Ltd.

The group develops proprietary bioactive peptides and tissue technologies with potential applications across cosmetics, skincare and advanced materials, including alternatives to conventional leather.

Its commercial strategy includes developing and licensing technologies from its scientific platform while pursuing partnerships capable of bringing those technologies into end markets. BSF Enterprise shares trade on the London Stock Exchange under the symbol BSFA.

CelLBxHealth plc (LSE:CLBX) has highlighted new independent research showing that circulating tumor cells captured using its Parsortix platform reflected genetic characteristics found in glioblastoma tumor tissue, supporting further investigation of the technology for liquid biopsy applications in brain cancer.

The peer-reviewed study, published in JCO Precision Oncology, analysed Parsortix-enriched circulating tumor cells, or CTCs, from patients with glioblastoma. Researchers found that mutations and chromosomal alterations detected in the captured cells corresponded with changes identified in tumor tissue.

The study also proposed a numerical CTC threshold for distinguishing patients with glioblastoma from healthy controls. Combined with CelLBxHealth’s own data in glioblastoma, the findings provide further evidence for evaluating Parsortix-based CTC analysis as a complementary approach to diagnosis and disease monitoring.

The potential application is particularly relevant in glioblastoma because obtaining repeat tissue biopsies can carry significant risks, while conventional imaging may be difficult to interpret in some circumstances. A blood-based approach capable of providing molecular information could therefore offer a less invasive way of generating additional information about a patient’s disease.

Parsortix is designed to capture CTCs from blood while preserving them for subsequent molecular analysis. The cells can then be assessed using established laboratory techniques covering areas such as imaging, genomic analysis and protein profiling.

While the study strengthens the research case for Parsortix in glioblastoma, further clinical development would be needed to establish how the approach could ultimately be incorporated into diagnosis or patient monitoring.

CelLBxHealth’s wider outlook remains constrained by significant financial challenges and weak technical indicators. Recent corporate developments provide some positive momentum, but financial performance and valuation considerations continue to weigh on the overall picture.

More about CelLBxHealth plc

CelLBxHealth plc is a circulating tumor cell technology company developing solutions for oncology research, drug development and clinical applications.

Its patent-protected Parsortix platform captures circulating tumor cells from blood for subsequent molecular analysis using standard laboratory technologies, including imaging, proteomic profiling and genomic testing.

The company is pursuing revenue through three principal areas: sales of Parsortix instruments and consumables through CRO and clinical laboratory relationships, clinical trial support and assay development from its GCLP-compliant UK facility, and lab-developed tests advanced internally and through strategic collaborations.

This model gives CelLBxHealth exposure to liquid biopsy and precision oncology applications spanning cancer research, pharmaceutical development and potential clinical testing. Its shares trade on AIM under the symbol CLBX.

URU Metals (LSE:URU) has completed an integrated 3D geological model for the Zeb Nickel Project in South Africa, combining multiple exploration datasets to improve targeting of higher-grade nickel-copper-platinum group element mineralisation ahead of its next drilling campaign.

The model brings together drilling results, geological interpretation, magnetic and gravity surveys, and airborne and ground electromagnetic data. The work identified a close spatial relationship between Critical Zone rocks containing known Ni-Cu-PGE mineralisation and the project’s strongest electromagnetic responses.

URU expects the improved geological understanding to help refine drilling along the interpreted mineralised corridor, particularly within the higher-grade Zone 2 area. More targeted drilling could also contribute towards the company’s longer-term objective of establishing a maiden resource estimate.

Another focus emerging from the modelling is Ground FDEM Target 1, a distinct electromagnetic conductor that coincides with a gravity anomaly. The target is located where a chonolith extending from the Uitloop II ultramafic body opens into a larger intrusive chamber.

URU considers this geological setting prospective for sulphide accumulation and plans to test Target 1 for potential semi-massive to massive Ni-Cu-PGE sulphides.

The next drilling programme will therefore have two main objectives: extending the known higher-grade mineralisation at Zone 2 and testing the newly prioritised Target 1. Individual drill targets will be ranked against the exploration budget available to the company.

The enhanced 3D model could help URU use its exploration capital more efficiently by improving drill-hole placement and concentrating expenditure on areas considered to have the strongest geological and geophysical support.

Financial constraints nevertheless remain an important consideration. URU is still pre-revenue, continues to consume cash and has negative equity, leaving future exploration progress dependent on maintaining sufficient funding.

Technical indicators also remain weak, with a negative MACD and the shares trading below key short-term moving averages. Recent progress, including securing the mining right and completing an oversubscribed financing, provides some offset as the company prepares for further exploration.

More about URU Metals

URU Metals is a mineral exploration company focused on the Zeb Nickel Project in Limpopo, South Africa.

The project targets nickel, copper and platinum group element sulphide mineralisation within the Bushveld Complex’s Critical Zone. URU is using geological modelling, geophysical surveys and drilling to define higher-grade mineralised areas and investigate the potential for semi-massive to massive sulphide accumulations.

The company’s shares trade on the London Stock Exchange under the symbol URU.

Acuity RM Group (LSE:ACRM) has secured a new software contract with a prime defence contractor for its STREAM Classic cybersecurity risk management platform, adding more than £100,000 in annual recurring revenue.

Under the agreement, Acuity will deploy two on-premises instances of STREAM Classic to support the contractor’s involvement in a high-profile international defence programme. The installation model has been selected to meet the stringent security requirements associated with the project.

The software agreement is expected to be supplemented by a separate contract covering implementation and configuration services, potentially adding further revenue from the deployment.

Defence is already Acuity’s largest market, and the latest contract strengthens its presence in a sector where cybersecurity, data control and configurable risk management systems are particularly important.

Management also said discussions are underway with other prime contractors participating in the same international defence programme. Additional agreements could expand Acuity’s involvement while increasing recurring software revenue and associated services income.

The contract highlights the flexibility of the STREAM platform, particularly its ability to operate through on-premises installations in security-sensitive environments rather than relying exclusively on externally hosted infrastructure.

Despite the commercial progress, Acuity’s broader financial position remains challenging. Persistent losses and negative cash flow continue to weigh on the outlook, with cash generation showing signs of further deterioration.

The balance sheet provides some support through relatively low debt and equity funding, but valuation measures remain difficult to assess positively while earnings are negative and there is no dividend contribution.

Technical indicators also remain cautious, with the shares trading below major moving averages and the MACD in negative territory. Future contract wins and improvements in recurring revenue and cash generation could therefore become important indicators of whether commercial momentum is translating into stronger financial performance.

More about Acuity RM Group

Acuity RM Group is a UK AIM-listed software company specialising in cybersecurity and wider risk management solutions.

Its STREAM platform collects, analyses and manages risk information to help organisations make more informed decisions. Customers operate across sectors including government, defence, broadcasting, utilities, manufacturing and healthcare.

Acuity’s strategy centres on generating long-term organic growth from its risk management technology while also considering complementary acquisition opportunities. Its shares trade on AIM under the symbol ACRM.

InterContinental Hotels Group (LSE:IHG) delivered higher revenue, profit and earnings in the first half of 2026, supported by RevPAR growth, expanding margins and record hotel development activity across its global portfolio.

Revenue from reportable segments increased 7%, while operating profit rose 10% and adjusted earnings per share advanced 13%. Global revenue per available room, or RevPAR, grew 4.1%, with positive contributions from the Americas and Greater China.

Performance across EMEAA also supported the half-year result despite weaker conditions in the Middle East. Combined with continued cost discipline, the growth helped strengthen profitability and supported higher shareholder distributions.

Development activity reached record levels during the period. IHG opened 31,500 rooms across 197 hotels and signed another 49,200 rooms, taking net system growth to 5%. Its development pipeline expanded to approximately 348,000 rooms, providing further capacity for future expansion.

The group is also progressing with its $950 million share buyback programme and expects to return more than $1.2 billion to shareholders during 2026. Management maintained its expectations for full-year profit and earnings.

Cash generation remained strong, with adjusted free cash flow increasing to $360 million. IHG’s fee-based business model and operating efficiencies helped lift its fee margin to almost 66%, supporting investment in growth alongside shareholder returns.

Net debt nevertheless increased to $3.7 billion, primarily reflecting dividends and share repurchases. The higher debt level, together with negative equity, remains an important balance-sheet consideration despite the strength of underlying cash generation.

Overall operating momentum remains positive, supported by hotel development, free cash flow and continued capital returns. The technical picture is more neutral, while the relatively high P/E valuation and modest dividend yield provide less support from a valuation perspective.

More about InterContinental Hotels Group

InterContinental Hotels Group is a global hospitality business with 21 hotel brands spanning the luxury, premium, essentials and suites segments.

The group has more than one million rooms across approximately 7,100 hotels in more than 100 countries, alongside a development pipeline of around 2,400 properties. It also operates the IHG One Rewards loyalty programme, which has more than 160 million members.

Its portfolio includes brands such as InterContinental, Holiday Inn, Crowne Plaza, Kimpton and Iberostar Beachfront Resorts. Around 400,000 people work across IHG-branded hotels and corporate offices worldwide.

InterContinental Hotels Group PLC is incorporated in England and Wales and has shares listed in London and New York.